Dipeptidyl Peptidase-4 Inhibition in Patients with Type 2 Diabetes Treated with Saxagliptin, Sitagliptin, or Vildagliptin

por Tatosian, Daniel A., Guo, Ying, Schaeffer, Andrea K., Gaibu, Natalia, Popa, Serghei, Stoch, Aubrey, Langdon, Ronald B., Kauh, Eunkyung A.
Publicado 2013

546. Therapeutic Effect of Regdanvimab in Patients with Mild to Moderate COVID-19: Day 28 Results from a Multicentre, Randomised, Controlled Pivotal Trial

por Ison, Michael G, Kim, Jin Yong, Sandulescu, Oana, Preotescu, Liliana-Lucia, Martinez, Norma Erendira Rivera, Dobryanska, Marta, Birlutiu, Victoria, Miftode, Egidia Gabriela, Gaibu, Natalia, Caliman-Sturdza, Olga Adriana, Florescu, Simin-Aysel, Streinu-Cercel, Anca, Lee, Sang Joon, Kim, Sung Hyun, Chang, Il Sung, Bae, Yun Ju, Suh, Jee Hye, Kim, Mi Rim, Chung, Da Re, Kim, Sun Jung, Lee, Seul Gi, Park, Ga Hee, Eom, Joong Sik
Publicado 2021

A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019

por Kim, Jin Yong, Săndulescu, Oana, Preotescu, Liliana-Lucia, Rivera-Martínez, Norma E, Dobryanska, Marta, Birlutiu, Victoria, Miftode, Egidia G, Gaibu, Natalia, Caliman-Sturdza, Olga, Florescu, Simin-Aysel, Shi, Hye Jin, Streinu-Cercel, Anca, Streinu-Cercel, Adrian, Lee, Sang Joon, Kim, Sung Hyun, Chang, Ilsung, Bae, Yun Ju, Suh, Jee Hye, Chung, Da Rae, Kim, Sun Jung, Kim, Mi Rim, Lee, Seul Gi, Park, Gahee, Eom, Joong Sik
Publicado 2022